This website uses cookies to enhance the user experience.
K

KAPPA SOLUTIONS AS882 512 142

Research
Limited company
4. etasje Silurveien 2B 0380 OSLO, Norge

KAPPA SOLUTIONS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO
Chairman of the board
Years since formation
25 years
since Oct 23, 2000
Type
Limited company
VAT registered
Yes
Number of employees
8

Ownership

Number of shares and share classes
900
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2024
22,680,675
NOK
Annual total result 2024
800,828
NOK
Total equity 2024
17,261,536
NOK
Last update: Jul 22, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-

Others

NameRoleShares
R
RSM NORGE AS
Auditor-
S
STABEKK REGNSKAPSSERVICE AS
Accountant-
A
AMESTO ACCOUNTHOUSE AS
Accountant-
Last update: Apr 1, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
K
KAPPA BIOSCIENCE AS
Ordinary shares
900
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 0
    Operating profit 2024: NOK -269,161
    Employees: 0

Financials

in NOK

Summary

Year202420232022
Total operating income
22,680,675
21,915,171
21,699,546
Annual Total Result
800,828
3,200,631
4,282,688
Total assets
21,011,244
21,590,012
18,649,835
Total liabilities
3,749,708
5,129,304
5,389,758
Total equity
17,261,536
16,460,708
13,260,077

P&L

Year202420232022
Total operating income
22,680,675
21,915,171
21,699,546
Total operating costs
22,010,852
18,220,562
16,347,550
Operating result
669,822
3,694,609
5,351,996
Financial income/costs
356,859
408,763
139,342
Profit before tax
1,026,682
4,103,372
5,491,338
Total tax & extraordinary income/cost
225,854
902,741
1,208,650
Annual Total Result
800,828
3,200,631
4,282,688

Balance overview

Year202420232022
Total fixed assets
411,740
11,108,122
10,953,461
Total current assets
20,599,504
10,481,890
7,696,374
Total assets
21,011,244
21,590,012
18,649,835
Short term debt
3,749,708
5,129,304
5,389,758
Long term debt
0
0
0
Total liabilities
3,749,708
5,129,304
5,389,758
Contributed capital
200,000
200,000
200,000
Retained earnings
17,061,536
16,260,708
13,060,077
Total equity
17,261,536
16,460,708
13,260,077
Total equity and liabilities
21,011,244
21,590,012
18,649,835

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology